In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  DiMezzo, Tracy L ^a   Ruthel, Gordon ^a   Brueggemann, Ernst E ^a   Hines, Harry B ^a   Ribot, Wilson J ^a   Chapman, Carol E ^a   Powell, Bradford S ^a   Welkos, Susan L ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; LYSOSOME ENZYME; MITOCHONDRIAL PROTEIN; UNCLASSIFIED DRUG; VIRULENCE ANTIGEN; VIRULENCE FACTOR; BACTERIAL ANTIGEN;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INTRACELLULAR TRANSPORT; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PLAGUE; PROTEIN INTERACTION; PROTEIN LOCALIZATION; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS; HELA CELL; IMMUNOLOGY; METABOLISM; PATHOGENICITY; TRANSPORT AT THE CELLULAR LEVEL; VIRULENCE; WESTERN BLOTTING;

YERSINIA; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS;

ANTIGENS, BACTERIAL; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; FLOW CYTOMETRY; HELA CELLS; HUMANS; MACROPHAGES; PLAGUE; VIRULENCE; YERSINIA PESTIS;

EID: 67650904470     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006281     Document Type: Article

References (80)

1. Butler T (1983) Plague and other Yersinia infections. London (UK): Plenum Medical.
2. Perry RD, Fetherston JD (1997) Yersinia pestis-etiological agent of plague. Clin Microbiol Rev 10: 35-66.
3. 2+-response plasmid pCD1 of Yersinia pestis KIM5. Infect Immun 66: 5611-5623.
4. Burrows TW, Bacon GA (1958) The effects of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis. Br J Exp Pathol 39: 278-291.
5. Burrows TW (1963) Virulence of Pasteurella pestis and immunity to plague. Ergeb Mikrobiol Immunitatsforsch Exp Ther 37: 59-113.
6. Friedlander AM, Welkos SL, Worsham PL, Andrews GP, Heath DG, et al. (1995) Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis 21: 178-181.
7. Galyov EE, Smirnov OY, Karlishev AV, Volkovoy KI, Denesyuk AL, et al. (1990) Nucleotide sequence of the Yersinia pestis gene encoding F1 antigen and the primary structure of the protein. Putative T and B cell epitopes. FEBS Lett 277: 230-232.
8. Galyov EE, Karlyshev AV, Chernovskaya TV, Dolgikh DA, Smirnov OY, et al. (1991) Expression of the envelope antigen F1 of Yersinia pestis is mediated by the product of caf1M gene having homology with the chaperone protein PapD of Escherichia coli. FEBS Lett 286: 79-82.
9. Karlyshev AV, Galyov EE, Abramov VM, Zay'yalov VP (1992) Caf1R gene and its role in the regulation of capsule formation of Y. pestis. FEBS Lett 305(1): 37-40.
10. Lindler LE, Plano GV, Burland V, Mayhew GF, Blattner FR (1998) Complete DNA sequence and detailed analysis of the Yersinia pestis KIM5 plasmid encoding murine toxin and capsular antigen. Infect Immun 66: 5731-5742.
11. Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MTG, et al. (2001) Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413: 523-527.
12. Welkos SL, Andrews GP, Lindler LE, Snellings NJ, Strachan SD (2004) Mu dI1(Ap lac) mutagenesis of Yersinia pestis plasmid pFra and identification of temperature-regulated loci associated with virulence. Plasmid 51: 1-11.
13. Ferber DM, Brubaker RR (1981) Plasmids in Yersinia pestis. Infect Immun 31: 839-841.
14. Sodeinde O, Subrahmanyam YVBK, Stark K, Quan T, Bao Y, et al. (1992) A surface protease and the invasive character of plague. Science 258: 1004-1007.
15. Welkos SL, Friedlander AM, Davis KJ (1997) Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain CO92. Microb Pathog 23: 211-223.
16. Welkos SL, Pitt ML, Martinez M, Friedlander A, Vogel P, et al. (2002) Determination of the virulence of the pigmentation-deficient and pigmentation-plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 22: 2206-2214.
17. Lathom W, Price P, Miller V, Goldman W (2007) A plasminogen-activating protease specifically controls the development of primary pneuominc plague. Science 315: 509-513.
18. Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, et al. (1998) The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 62: 1315-1352.
19. Nilles ML, Fields KA, Straley SC (1998) The V antigen of Yesinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG. J Bacteriol 180: 3410-3420.
20. Pettersson J, Holmstrom A, Hill J, Leary S, Frithz-Lindsten E, et al. (1999) The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 32: 961-976.
21. Une T, Nakajima R, Brubaker RR (1987) Roles of V antigen in promoting virulence in Yersiniae. Contrib Microbiol Immunol 9: 179-185.
22. Viboud GI, Bliska JB (2005) Yersinia Outer Proteins: Role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 59: 69-89.
23. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC (2004) The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun 72: 4589-4602.
24. Anderson Jr GW, Leary SE, Williamson ED, Titball RW, Welkos SL, et al. (1996) Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect Immun 64: 4580-4585.
25. Nakajima R, Brubaker RR (1993) Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 61: 23-31.
26. Nedialkov YA, Motin VL, Brubaker RR (1997) Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect Immun 65: 1196-1203.
27. Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, et al. (2005) Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plage. Biotech Prog 21: 1490-1510.
28. Weeks S, Hill J, Friedlander A, Welkos S (2002) Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis. Microb Pathog 32: 227-237.
29. Nakajima R, Motin VL, Brubaker RR (1995) Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 63: 3021-3029.
30. Sing A, Roggenkamp A, Geiger AM, Heesemann J (2002) Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J Immunol 168: 1315-1321.
31. Holmstrom A, Olsson J, Cherepanov P, Maier E, Nordfelth R, et al. (2001) LcrV is a channel size-determining component of the Yop effector translocon of Yersinia. Mol Microbiol 39: 620-632.
32. Mueller CA, Broz P, Muller SA, Ringler P, Erne-Brand F, et al. (2005) The V-antigen of Yersinia forms a distinct structure at the tip of the injectisome needles. Science 310: 674-676.
33. Skrzypek E, Cowan C, Straley SC (1998) Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus. Mol Microbiol 30: 1051-1065.
34. Fields KA, Straley SC (1999) LcrV of Yersinia pestis enters infected eukaryotic cells by a virulence plasmid-independent mechanism. Infect Immun 67: 4801-4813.
35. Ryning FW, Remington JS (1978) Effect of cytochalasin D on Toxoplasma gondii cell entry. Infect Immun 20: 739-743.
36. Hakansson S, Schesser K, Persson C, Galyov EE, Rosqvist R, et al. (1996) The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO 15: 5812-5823.
37. Bolte S, Cordelieres FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microscopy 224: 213-32.
38. Zinchuk V, Zinchuk O, Okada T (2007) Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem Cytochem 40: 101-111.
39. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O (2005) Plague bacteria target immune cells during infection. Science 309: 1739-1741.
40. Hu H, Sa Q, Koehler TM, Aronson AI, Zhou D (2006) Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell Microbiol 8: 1634-1642.
41. Cornelis GR (2002) The Yersinia Ysc-Yop virulence apparatus. Int J Med Microbiol 291: 455-462.
42. Marenne MN, Journet L, Mota LJ, Cornelis GR (2003) Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN. Microb Pathog 35: 243-258.
43. Nordfelth R, Kauppi AM, Norberg HA, Wolf-Watz H, Elofsson M (2005) Small-molecule inhibitors specifically targeting type III secretion. Infect Immun 73: 3104-3114.
44. 2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J Biol Chem 273: 10223-10231.
45. 2+ channels in rat heart. J Physiol 536: 387-396.
46. Griffiths G, Hoflack B, Simons K, Mellman I, Kornfeld S (1988) The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell 52: 329-341.
47. Lin SX, Mallet WG, Huang AY, Maxfield FR (2004) Endocytosed cation-independent mannose 6-phosphate receptor traffics via the endocytic recycling compartment en route to the trans-Golgi network and a subpopulation of late endosomes. MBC 15: 721-733.
48. Alveraz-Dominguez C, Roberts R, Stahl PD (1997) Internalized Listeria monocytogenes modulates intracellular trafficking and delays maturation of the phagosome. J Cell Science 110: 731-743.
49. MacAry PA, Lindsay M, Scott MA, Craig JIO, Luzio JP, et al. (2001) Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells. PNAS 98: 3982-3987.
50. Tuma PL, Nyasae LK, Backer JM, Hubbard AL (2001) Vsp34p differentially regulates endocytosis from the apical and basolateral domain in polarized hepatic cells. J Cell Biol 154: 1197-1208.
51. Cataldo AM, Mathews PM, Boyer Boiteau A, Hassinger LC, Peterhoff CM, et al. (2008) Down syndrome fibroblast model of Alzheimer-related endosome pathology. Accelerated endocytosis promotes late endocytic defects. Amer J Pathol 173: 370-383.
52. Feng Y, Press B, Wandinger-Ness A (1995) Rab7: An important regulator of late endocytotic membrane traffic. J Cell Biol 131: 1435-1452.
53. Sobo K, LeBlanc I, Luyet PP, Fivaz M, Ferguson C, et al. (2007) Late endosomal cholesterol accumulation leads to impaired intra-endosomal trafficking. PLoS One 2: e851.
54. Collier RJ, Young JA (2003) Anthrax toxin. Annu Rev Cell Dev Biol 19: 45-70.
55. Young JA, Collier RJ (2007) Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem 76: 243-265.
56. Blanke SR, Milne JC, Benson EL, Collier RJ (1996) Fused polycationic peptide mediates delivery of diphtheria toxin A chain to the cytosol in the presence of anthrax protective antigen. Proc Natl Acad Sci 93: 8437-8442.
57. Falnes PO, Sandvig K (2000) Penetration of protein toxins into cells. Curr Opin Cell Biol 12: 407-413.
58. Jesenberger V, Procyk KJ, Yuan J, Reipert S, Baccarini M (2000) Salmonella-induced caspase-2 activation in macrophages: a novel mechanism in pathogen-mediated apoptosis. J Exp Med 192: 1035-1046.
59. Johannes L, Decaudin D (2005) Protein toxins: intracellular trafficking for targeted therapy. Gene Ther 12: 1360-1368.
60. Johannes L, Goud B (2000) Facing inward from compartment shores: how many pathways were we looking for? Traffic 1: 119-123.
61. Lord JM, Roberts LM (1998) Retrograde transport: going against the flow. Curr Biol 8: R56-R58.
62. Terebiznik MR, Vazquez CL, Torbicki K, Banks D, Wang T, et al. (2006) Helicobacter pylori VacA toxin promotes bacterial intracellular survival in gastric epithelial cells. Infect Immun 74: 6599-6614.
63. Vonderheit A, Helenius A (2005) Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLoS Biol 3: e233.
64. Sandvig K, van Deurs B (2000) Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives. EMBO J 19: 5943-5950.
65. Abrami L, Liu S, Cosson P, Leppla SH, van der Good GF (2003) Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol 160: 321-328.
66. Johannes L, Lamaze C (2002) Clathrin-dependent or not: is it still the question? Traffic 3: 443-451.
67. Morris RE, Gerstein AS, Bonventre PF, Saelinger CB (1985) Receptor mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun 50: 721-727.
68. Moya M, Dautry-Varsat A, Goud B, Louvard D, Boquet P (1985) Inhibition of coated pit formation in Hep2 cells blocks the cytotoxicity of diphtheria toxin but not that of ricin toxin. J Cell Biol 101: 548-559.
69. Ricci V, Galmiche A, Doye A, Necchi V, Solcia E, et al. (2000) High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-anchored protein and is not blocked by inhibition of the clathrin-mediated pathway of endocytosis. Mol Biol Cell 11: 3897-909.
70. Sandvig K, Grimmer S, Iversen TG, Rodal K, Torgersen ML, et al. (2000) Ricin transport into cells: studies of endocytosis and intracellular transport. Int J Med Microbiol 290: 415-420.
71. Shin JS, Abraham SN (2001) Cell biology. Caveolae - not just craters in the cellular landscape. Science 293: 1447-1448.
72. Hehnly H, Sheff D, Stamnes M (2006) Shiga toxin facilitates its retrograde transport by modifying microtubule dynamics. Mol Biol Cell 17: 4379-4389.
73. Johannes L (2002) The epithelial cell cytoskeleton and intracellular trafficking. I. Shiga toxin B-subunit system: retrograde transport, intracellular vectorization, and more. Am J Physiol Gastrointest Liver Physiol 283: G1-G7.
74. Khine AA, Tam P, Nutikka A, Lingwood CA (2004) Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Glycobiol 14: 701-712.
75. Mallard F, Antony C, Tenza D, Salamero J, Goud B, et al. (1998) Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J Cell Biol 143: 973-990.
76. Yu M, Haslam DB (2005) Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ/ERdj3. Infect Immun 73: 2524-2532.
77. Uchiva K, Barbieri MA, Funato K, Shah AH, Stahl PD, et al. (1999) A Salmonella virulence protein that inhibits cellular trafficking. EMBO J 18: 3924-3933.
78. Willhite DC, Blanke SR (2004) Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cell Microbiol 6: 143-154.
79. Takizawa T, Anderson CL, Robinson JM (2003) A new method to enhance contrast of ultrathin cyrosections for immunoelectron microscopy. J Histochem Cytochem 51: 31-39.
80. Bashaw J, Norris S, Weeks S, Trevino S, Adamovicz JJ, et al. (2007) Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin Vaccine Immunol 14: 605-616.